N/A
N=37
A Unified Treatment for Anxiety Disorders
Emotional Disorders · Anxiety Disorders
Bottom Line
View on ClinicalTrials.gov: NCT00586001 ↗Enrolled (actual)
37
Serious AEs
0.0%
Results posted
Dec 2018
Primary outcome: Primary: Anxiety Disorders Interview Schedule for DSM-IV — 5.23; 5.09; 3.18; 5.14 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Boston University Charles River Campus
- Primary completion
- Nov 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Anxiety Disorders Interview Schedule for DSM-IV |
5.23; 5.09; 3.18; 5.14 | — |
| SECONDARY Structured Interview Guide for the Hamilton Anxiety Rating Scale |
16.15; 14.36; 7.39; 13.08 | — |
| SECONDARY Structured Interview Guide for the Hamilton Depression Rating Scale |
10.35; 10.09; 5.49; 7.85 | — |
| SECONDARY Positive and Negative Affect Scale |
28.81; 28.00; 32.84; 27.17; 26.62; 24.36 | — |
| SECONDARY Beck Depression Inventory - II |
11.96; 11.73; 4.21; 11.45 | — |
| SECONDARY Beck Anxiety Inventory |
19.08; 16.91; 8.27; 12.22 | — |
| SECONDARY Work and Social Adjustment Scale |
16.04; 16.46; 7.62; 13.14 | — |
| SECONDARY Panic Disorder Severity Scale - Self Report Version |
7.65; 7.09; 2.77; 6.20 | — |
| SECONDARY Penn State Worry Questionnaire |
62.27; 62.55; 49.18; 60.30 | — |
| SECONDARY Social Interaction Anxiety Scale |
28.19; 38.18; 23.32; 37.60 | — |
| SECONDARY Quality of Life Inventory |
35.46; 32.45; 46.73; 34.67 | — |
| SECONDARY Yale-Brown Obsessive Compulsive Scale |
8.81; 7.18; 6.09; 8.65 | — |
| SECONDARY Emotion Regulation Questionnaire - 2 |
55.40; 60.36; 59.95; 60.00 | — |
| SECONDARY BIS/BAS Scales (Carver & White, 1994) |
24.15; 24.45; 22.32; 23.60; 38.09; 35.18 | — |
| SECONDARY Affective Control Scale |
140.92; 141.00; 106.36; 141.60 | — |
| SECONDARY Anxiety Sensitivity Index |
29.62; 29.27; 19.36; 25.50 | — |
| SECONDARY The Thought-Action Fusion Scale (Shafran et al., 1996) |
13.46; 16.82; 11.43; 16.90 | — |
| SECONDARY Intolerance of Uncertainty Scale (IUS) |
40.38; 39.27; 27.77; 40.25 | — |
| SECONDARY The Trait Meta-Mood Scale (TMMS; Salovey et al., 1995) |
76.83; 76.50; 50.83; 51.30; 39.43; 37.40 | — |
Summary
The purpose of this study is to develop a new psychological therapy for a variety of different types of emotional disorders. The study will compare symptoms and functioning of clients who receive the treatment with those who do not, and will include a number of assessments before, during, and after treatment. We predict that patients receiving active treatment will show improved functioning relative to wait-list control.
Eligibility Criteria
Inclusion Criteria
- Primary Diagnosis of a DSM-IV Anxiety Disorder
Exclusion Criteria
- Previous treatment with cognitive-behavioral therapy
- Receiving concurrent psychological treatments during study
- If on psychotropic medicine, requirement for stable dose for at least three months before treatment
Data sourced from ClinicalTrials.gov (NCT00586001). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.